PRESCRIPTION DRUG PLAN ENHANCEMENT – EFFECTIVE JANUARY 1, 2027

In January 2025, the Superior Officers Council successfully transitioned its Medicare-eligible members and their Medicare-eligible dependents to the OptumRx Employer Group Waiver Plan (EGWP), a Medicare Part D prescription drug plan designed to meet the requirements of the federal Inflation Reduction Act of 2022.

Since its implementation, the EGWP has proven to be a successful program, providing our Medicare-eligible membership with comprehensive prescription drug coverage while helping to reduce out-of-pocket expenses.

We are pleased to announce an additional benefit enhancement effective January 1, 2027:

The Superior Officers Council will eliminate the 15% Tier 1 copayment on generic medications.

This enhancement means that covered Tier 1 generic medications will be available at no cost to eligible members and dependents, further reducing prescription drug expenses.

2027 Annual Maximum Out-of-Pocket (MOOP) Update

The annual Maximum Out-of-Pocket (MOOP) limit for prescription drugs will increase to
$2,400 effective January 1, 2027. This represents a change to the plan’s annual out-of-pocket limit in accordance with updated Medicare Part D requirements.

The Superior Officers Council remains committed to strengthening the benefits available to our membership while continuing to provide comprehensive, affordable prescription drug coverage.